Aurolab房水引流植入物在原发性先天性青光眼与无晶状体性青光眼儿童眼中的长期手术结局比较
回顾性比较介入性病例系列,纳入2013年1月至2016年12月接受AADI手术且随访至少4年的连续PCG或APG眼。4年累积失败率PCG为57%(95%CI 43%至72%),APG为40%(95%CI 28%至56%),p=0.11;APG组1年平均眼压更低且降眼压药物使用更少。APG眼在4年随访中结局相对优于PCG眼,再手术占失败原因的70%以上。
要点
- APG组1年平均眼压13.6±8.1 mmHg,低于PCG组17.6±7.5 mmHg(p=0.02)。
- APG组1年降眼压药物使用0.8±1.0种,少于PCG组1.5±1.0种(p=0.01)。
- 4年累积失败率PCG 57%(95%CI 43%至72%)vs APG 40%(95%CI 28%至56%),p=0.11。
核心结论
- 在4年随访中,APG眼接受AADI植入后的结局相对优于PCG眼。
- 再手术占失败原因的70%以上。
研究设计与样本
- 回顾性比较介入性病例系列,从计算机数据库提取2013年1月至2016年12月间接受AADI手术且随访至少4年的连续PCG或APG眼。
- 共89眼接受AADI植入,其中PCG 42眼(47%),APG 47眼(53%),两组基线可比。
- 失败定义为:术后3个月后连续两次随访眼压>21 mmHg或较基线降低<20%、连续两次随访眼压≤5 mmHg、因青光眼或并发症再手术、或丧失光感。
主要发现
- 1年时APG组平均眼压13.6±8.1 mmHg,低于PCG组17.6±7.5 mmHg(p=0.02)。
- 1年时APG组降眼压药物使用0.8±1.0种,少于PCG组1.5±1.0种(p=0.01)。
- 4年累积失败率PCG为57%(95%CI 43%至72%),APG为40%(95%CI 28%至56%),p=0.11。
- PCG眼管相关并发症48% vs APG眼38%(p=0.07),再手术次数PCG 40% vs APG 32%(p=0.02)。
关键数值与推荐
- 失败判定标准:术后3个月后连续两次随访眼压>21 mmHg或较基线降低<20%。
- 失败判定标准:连续两次随访眼压≤5 mmHg。
- 失败判定标准:因青光眼或并发症再手术,或丧失光感。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the outcomes of the Aurolab aqueous drainage implant (AADI) placed in eyes with refractory primary congenital glaucoma (PCG) versus aphakic glaucoma (APG). DESIGN: Retrospective comparative interventional case series. METHODS: Case files of consecutive eyes with PCG or APG that underwent AADI surgery between January 2013 and December 2016 and had a minimum 4 years follow-up were extracted from a computerised database. Failure was defined as intraocular pressure (IOP)>21 mm Hg or reduced<20% below baseline on two consecutive follow-up visits after 3 months, IOP≤5 mm Hg on two consecutive follow-up visits after 3 months, reoperation for glaucoma or a complication, or loss of light perception. RESULTS: Eighty-nine eyes underwent AADI placement, including 42 eyes (47%) with PCG and 47 eyes (53%) with APG. Both groups were comparable at baseline. At 1 year, the APG group had lower mean IOP (13.6±8.1 mm Hg vs 17.6±7.5 mm Hg, p=0.02) with use of fewer IOP-lowering medications (0.8±1.0 vs 1.5±1.0, p=0.01) than the PCG group. The cumulative failure rate at 4 years was 57% (95% CI 43% to 72%) in PCG versus 40% (95% CI 28% to 56%) in the APG eyes (p=0.11). Eyes with PCG had greater tube-related complications (48% vs 38%, p=0.07) and number of reoperations (40% vs 32%, p=0.02) compared with eyes with APG. CONCLUSIONS: Eyes with APG had relatively better outcomes after AADI placement compared with PCG during 4 years of follow-up. Reoperations accounted for more than 70% of the failures.
引用
- Puthuran GV, Ramesh S, Maheswari P, et al. Long-term surgical outcomes of Aurolab aqueous drainage implant in pediatric eyes with primary congenital glaucoma versus aphakic glaucoma. Br J Ophthalmol. 2023. PMID: 36229180. doi:10.1136/bjo-2022-321571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。